Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-17 Sale | 2020-03-18 6:00 pm | Ra Pharmaceuticals Inc. | RARX | Ricardo Alonso See Remarks | 2,288 | $44.25 | $101,244 | 0 (Direct) | View |
| 2020-03-16 Sale | 2020-03-18 6:00 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $45.16 | $478,521 | 91,896 (Direct) | View |
| 2020-02-18 Sale | 2020-02-20 6:52 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $46.61 | $493,850 | 102,491 (Direct) | View |
| 2020-01-17 Sale | 2020-01-21 6:32 pm | Ra Pharmaceuticals Inc. | RARX | Ricardo Alonso See Remarks | 2,285 | $47.02 | $107,441 | 2,288 (Direct) | View |
| 2020-01-15 Sale | 2020-01-16 6:01 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $46.95 | $497,441 | 113,086 (Direct) | View |
| 2019-12-17 Sale | 2019-12-18 6:01 pm | Ra Pharmaceuticals Inc. | RARX | Ricardo Alonso See Remarks | 2,285 | $47.08 | $107,568 | 4,573 (Direct) | View |
| 2019-12-17 Sale | 2019-12-18 6:01 pm | Ra Pharmaceuticals Inc. | RARX | Read Simon Chief Scientific Officer | 10,000 | $47.08 | $470,821 | 52,376 (Direct) | View |
| 2019-12-16 Sale | 2019-12-18 6:00 pm | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $47.23 | $500,351 | 123,681 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-04-02 Disposition | 2020-04-03 09:28 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd BASKETT FOREST KERINS PATRICK J SANDELL SCOTT D 10% Owner | 6,135,234 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:03 am | N/A 2027-06-20 | Ra Pharmaceuticals Inc. | RARX | Mathers Edward T Director | 45,000 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A 2025-12-10 | Ra Pharmaceuticals Inc. | RARX | Treco Douglas A President and CEO | 1,226,949 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Treco Douglas A President and CEO | 234,707 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A 2026-03-01 | Ra Pharmaceuticals Inc. | RARX | Lubner David Charles Executive VP and CFO | 554,842 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Lubner David Charles Executive VP and CFO | 15,622 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A 2022-06-14 | Ra Pharmaceuticals Inc. | RARX | Ricardo Alonso See Remarks | 276,195 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Ricardo Alonso See Remarks | 2,973 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A 2026-06-16 | Ra Pharmaceuticals Inc. | RARX | Read Simon Chief Scientific Officer | 336,522 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Read Simon Chief Scientific Officer | 12,595 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 380,680 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 14,492 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A 2029-06-11 | Ra Pharmaceuticals Inc. | RARX | Cumbo Alexander Director | 40,000 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A 2026-03-10 | Ra Pharmaceuticals Inc. | RARX | PEARSON TIMOTHY R Director | 67,857 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A 2028-05-01 | Ra Pharmaceuticals Inc. | RARX | King John C Chief Commercial Officer | 327,658 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:01 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | King John C Chief Commercial Officer | 10,823 | $48 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:00 am | N/A 2027-06-20 | Ra Pharmaceuticals Inc. | RARX | Shah Rajeev M. Director 10% Owner | 45,000 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:00 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Shah Rajeev M. Director 10% Owner | 4,858,260 | $48 | 0 (Indirect) | View |
| 2020-04-02 Disposition | 2020-04-03 09:00 am | N/A 2026-03-10 | Ra Pharmaceuticals Inc. | RARX | Heft Robert Director | 67,857 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:00 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Director 10% Owner | 4,858,260 | $48 | 0 (Indirect) | View |
| 2020-04-02 Disposition | 2020-04-03 09:00 am | N/A 2029-06-11 | Ra Pharmaceuticals Inc. | RARX | Brennan Aoife Director | 40,000 | $0 | 0 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 6:00 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 91,896 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 6:00 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 91,896 (Direct) | View |
| 2020-02-18 Exercise | 2020-02-20 6:52 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 102,491 (Direct) | View |
| 2020-02-18 Exercise | 2020-02-20 6:52 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 102,491 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-16 6:01 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 113,086 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-16 6:01 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 113,086 (Direct) | View |
| 2019-12-17 Exercise | 2019-12-18 6:01 pm | N/A 2026-06-16 | Ra Pharmaceuticals Inc. | RARX | Read Simon Chief Scientific Officer | 10,000 | $0 | 52,376 (Direct) | View |
| 2019-12-17 Exercise | 2019-12-18 6:01 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Read Simon Chief Scientific Officer | 10,000 | $2.87 | 52,376 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 6:00 pm | N/A 2026-08-16 | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $0 | 123,681 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 6:00 pm | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Farzaneh-Far Ramin Chief Medical Officer | 10,595 | $5.6 | 123,681 (Direct) | View |